Theratechnologies (NASDAQ:THTX) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Theratechnologies (NASDAQ:THTX) released its earnings results on Thursday. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03, Yahoo Finance reports. The business had revenue of $22.60 million during the quarter. During the same quarter in the previous year, the company posted ($0.03) EPS. Theratechnologies updated its FY 2024 guidance to EPS.

Theratechnologies Trading Down 0.8 %

Shares of Theratechnologies stock opened at $1.26 on Friday. The firm’s 50 day moving average is $1.27 and its 200 day moving average is $1.34. The firm has a market capitalization of $57.70 million, a PE ratio of -6.61 and a beta of 1.41. Theratechnologies has a 1 year low of $0.88 and a 1 year high of $2.58.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.